Expects Q2 loss from operations of approximately $230M. “The individual market is a competitive healthcare marketplace that provides affordable, high-quality coverage for millions of consumers across the country,” said Mark Bertolini, CEO. “We are taking appropriate pricing actions for 2026 that reflect higher acuity in the individual market, and we will continue to take steps to deliver for our members, partners, and shareholders. Oscar has successfully navigated dynamic markets before and we remain committed to our long-term strategy to bring more employees, individuals, and families healthcare choices that fit their needs through the individual market.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR:
- Oscar Health downgraded to Sell from Neutral at UBS
- Oscar Health downgraded to Neutral from Overweight at Piper Sandler
- Option traders moderately bearish in Oscar Health with shares down 4.67%
- CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
- Wells Fargo downgrades Oscar Health to Underweight on cost trends